SEC Tracker
Get the app

Biolife Solutions BLFS

Biolife Solutions completes acquisition by Repligen

Form
8-K
Filed
Importance
Major
  1. Completed on Oct 6, 2026
  2. BioLife merged into Repligen
  3. Stockholders received 0.1442 shares and $11.25 per share
  4. BioLife delisted from Nasdaq

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Biolife Solutions files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.

  1. SI-BONE SIBN public float $800M, Jun 30, 2025
  2. Integra Lifesciences Holdings IART public float $925M, Jun 30, 2025
  3. Establishment Labs Holdings ESTA public float $975M, Jun 30, 2025
  4. Embecta EMBC public float $732M, Mar 31, 2025, over 18 months old
  5. Mimedx Group MDXG public float $719M, Jun 30, 2025